However, when I stepped on the scale after 30 days, there was no meaningful change in my weight
The study, which tested the drug in 529 patients with obesity and heart failure with preserved ejection fraction (HFpEF), demonstrated a 16.6-point increase at 52 weeks, with regard to the Clinical Summary Score (CSS) on the Kansas City Cardiomyopathy Questionnaire (KCCQ) a measure of symptoms of heart failure in comparison to an 8.7-point increase in the placebo group
Personalized dosing is crucial for GLP-1 medications, as it ensures your dosage aligns with your bodys needs, weight loss goals, medical history, and tolerance levels
During your evaluation at Klinic, your licensed clinician will thoroughly review your health history and confirm your eligibility
We partner exclusively with FDA-registered and inspected pharmacies to ensure that the medications, including Wegovy and our Compounded Semaglutide, are of the highest quality